ArticleOncoimmunology2025
A targeted MAVS fusion protein for controlled innate immune activation and antitumor therapy.
Muhan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleOncoimmunology2025
Muhan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.